Fanastomig

Approval Year

Name

Type

Language

Fanastomig

Official Name

English

fanastomig [INN]

Common Name

English

Immunoglobulin L-kappa-H-gamma1_G1(VH-CH1-h)_L-kappa dimer, anti-[Homo sapiens LAG3 (lymphocyte activating 3, lymphocyte-activation 3, CD223)] and anti-[Homo sapiens PDCD1 (programmed cell death 1, PD-1, PD1, CD279)], monoclonal antibody, bispecific

Common Name

English

[L-kappa-H-gamma1 heavy chain anti-LAG3 and anti-PDCD1 (1-665) [L-kappa anti-LAG3 (1-214) [V-KAPPA Musmus/Homsap (Mus musculus IGKV9-124*01 (88.4%) -IGKJ5*01 (91.7%) A120>Q (100)/Homo sapiens IGKV1-16*01 (84.2%) -IGKJ2*01 (90.9%) I126>L (106), CDR-IMGT [

Common Name

English

Code System Code Type Description

CAS

2761795-00-8

Created by admin on Sat Dec 16 16:13:58 GMT 2023 , Edited by admin on Sat Dec 16 16:13:58 GMT 2023

PRIMARY

INN

12694

Created by admin on Sat Dec 16 16:13:58 GMT 2023 , Edited by admin on Sat Dec 16 16:13:58 GMT 2023

PRIMARY

FDA UNII

1GCR6YY9NI

Created by admin on Sat Dec 16 16:13:58 GMT 2023 , Edited by admin on Sat Dec 16 16:13:58 GMT 2023

PRIMARY

ACTIVE MOIETY


					1GCR6YY9NI

Fanastomig